Lamivudine (150mg) + Nevirapine (200mg) + Zidovudine (300mg)
Zidolam N N 150 mg/300 mg/200 mg Tablet is used in the treatment of HIV infection.
1 Bottle of 60 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zidolam N N 150 mg/300 mg/200 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Zidolam N N 150 mg/300 mg/200 mg Tablet is a combination of three antiviral medicines: Lamivudine, Zidovudine and Nevirapine. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Zidolam N N 150 mg/300 mg/200 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Zidolam N N 150 mg/300 mg/200 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
You may experience fatigue while taking Zidolam N N 150 mg/300 mg/200 mg Tablet and this may affect your ability to drive.
Zidolam N N 150 mg/300 mg/200 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zidolam N N 150 mg/300 mg/200 mg Tablet may be needed. Please consult your doctor.
Zidolam N N 150 mg/300 mg/200 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Zidolam N N 150 mg/300 mg/200 mg Tablet may be needed. Please consult your doctor.
Use of Zidolam N N 150 mg/300 mg/200 mg Tablet is not recommended in patients with moderate to severe liver disease. Regular monitoring of liver function tests is advised while you are taking this medicine.
